Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQSV0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award represents a single delivery order issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program, a $30.3 billion government-wide acquisition strategy, with a contract ceiling of $499.999 billion and completion date of December 31, 2036. The company's established performance across multiple therapeutic categories and product lines—including oncology treatments, immunosuppressants, biologics, and specialty pharmaceuticals—positions it as a critical supplier for Department of Defense healthcare operations. As a prime contractor with no identified subcontractors, DMS Pharmaceutical Group leverages its small business status to supply comprehensive pharmaceutical products and medical consumables to federal military healthcare facilities worldwide through the DLA Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FQSV0?
SPE2DR26FQSV0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FQSV0 worth?
The government has obligated $16,584 on SPE2DR26FQSV0.
Is contract SPE2DR26FQSV0 an order under another contract?
Yes. SPE2DR26FQSV0 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSV0 competed?
The extent of competition for SPE2DR26FQSV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award